Table 3.
Refractive and Keratometric changes 12 to 18 months after transepithelial cross-linking in patients younger than 18 years old.
| Authors | Number of eyes | Age group (years) | Follow up time (months) | Change in DCVA (Snellen lines) | Change in KMax (D) | Change in Steep K (D) | Change in Average K (D) | Complications (number of eyes) |
|---|---|---|---|---|---|---|---|---|
| Transepithelial CXL with modified Riboflavin (Ricrolin) | ||||||||
| Buzzonetti et al, 2012101 | 13 | 8 - 18 | 18 | 1 | +4.9 | N/A | +0.2 | None |
| Magli et al 201399 | 14 | 12 - 17 | 12 | 0 | -1.14 | N/A | -1.63 | None |
| Salman et al 201398 | 22 | 13 - 18 | 12 | 3 | -2.3 | N/A | -2.03 | None |
| Transepithelial CXL with Iontophoresis | ||||||||
| Buzzonetti et al, 201586 | 14 | 10 - 18 | 15 | 1 | +0.4 | +0.2 | +0.2 | None |
| Magli et al 201687 | 13 | 11 - 18 | 18 | 1 | N/A | +0.3 | N/A | None |
DCVA: Distance Corrected Visual Acuity, KMax: Steepest Keratometry; KSteep: Steepest Simulated Keratometry; Average K: Average Keratometry